Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovasular events in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1, 2009, Pages 116-119

  Gonzales Gay, Miguel A ^a   Llorca, Javier ^b   Palomino Morales, Rogelio ^c   Gomez Acebo, Ines ^b   Gonzales Juanatey, Carlos ^a   Martin, Javier ^c  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c CSIC   (Spain)

Author keywords

Atherosclerosis; Cardiovascular disease; Genetics; HLA DRB1*04 shared epitope alleles; Nitric oxide synthases; Rheumatoid arthritis

Indexed keywords

ASPARTIC ACID; CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; GUANINE; HLA DR ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; THYMINE;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MYOCARDIAL ISCHEMIA; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 63049089491     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GONZALEZ-GAYMA, AONZALEZ-JUANATEY C, MARTIN J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 8-17.
2. DESSEIN PH, JOFFE BI, VELLER MG et al.: Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32: 435-42.
3. GONZALEZ-GAYMA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
4. GONZALEZ-GAY MA, GARCIA-PORRUA C, HAJEER AH: Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002; 31: 355-60.
5. GONZALEZ-JUANATEY C,TESTA A, GARCIA-CASTELO A et al.: HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003; 114: 647-52.
6. GONZALEZ-GAYMA, GONZALEZ-JUANATEY C, MARTIN J: Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 115-7.
7. MATTEY DL, THOMSON W, OLLIER WE et al.: Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: Results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007; 56: 1408-16.
8. OROZCO G, RUEDA B, MARTIN J: Genetic basis of rheumatoid arthritis. Biomed Pharmacother 2006; 60: 656-62.
9. YKI-JARKIVEN H, BERGHOLM R, LEIRISALO-REPO M: Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 630-4.
10. WEINBERG JB: Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review. Mol Med 1998; 4: 557-91.
11. WANG XL, WANG J: Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000; 70: 241-51.
12. SALVARANI C, CASALI B, NICOLI D et al.: Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 2003; 48: 3219-23.
13. OKSEL F, KESER G, OZMEN M et al.: Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behçet's disease. Clin Exp Rheumatol 2006; 24 (Suppl. 42): S79-82. Erratum in: Clin Exp Rheumatol 2007 25: 507-8.
14. GONZALEZ-GAY MA, OLIVER J, SANCHEZ E et al.: Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol 2005; 32: 2178-82.
15. MARTIN J, PACO L, RUIZ MP et al.: Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 2005; 32: 1081-5.
16. PASCUAL M, LOPEZ-NEVOT MA, CALIZ R et al.: Genetic determinants of rheumatoid arthritis: The inducible nitric oxide synthase (NOS2) gene promoter polymorphism. Genes Immun 2002; 3: 299-301.
17. GONZALEZ-GAY MA, LLORCA J, SANCHEZ E et al.: Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 2004; 43: 1182-5.
18. AMOLI MM, LOPEZ-AGREDA H, SUAREZ-AMOR O, MARTIN J, OLLIER WE, GONZALEZ-GAY MA: Endotheliai nitric oxide synthase polymorphisms in biopsy-proven erythema nodosurn from a defined population. Clin Exp Rheumatol 2007; 25: 624-6.
19. RADSTAKE TR, FRANSEN J, VAN RIEL PL, TOONEN E, COENEN M, DONN R: Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis. Ann Rheum Dis 2008; 67: 134-5.
20. DIMMELER S, FLEMING I, FISSLTHALER B, HERMANN C, BUSSE R, ZEIHER AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-5.